KING COMPOUND
Educational only, not financial advice. Capital at risk.

Thermo Fisher Scientific (TMO) stock analysis

A free, instant KC Score and technical read on Thermo Fisher Scientific, from the last 12 months of price data.

97A+
KC Score · TMO

Thermo Fisher Scientific

Strong, established uptrend with positive momentum.

$678.39+1.97% today98% of 52w range-1% vs high
Momentum100/100

3-month +34.1%, 6-month +38.2%.

Trend100/100

Price is above its 50-day and above its 200-day average; 50DMA above 200DMA.

Range strength98/100

Trading 1% below its 52-week high — 98% of the way up its yearly range.

Stability78/100

Annualised volatility ~31% — moderately choppy.

How the KC Score works

The KC Score is a transparent 0–100 read of Thermo Fisher Scientific's recent price behaviour, built from ~12 months of daily closing prices. Momentum weighs 3- and 6-month returns; Trend checks price against its 50- and 200-day moving averages; Range strength measures where it sits in its 52-week range; Stability reflects volatility. It is a descriptive technical summary — not a forecast, price target, or recommendation to buy or sell. Markets change daily; re-check before acting and do your own research.

What the KC Score says about Thermo Fisher Scientific

Thermo Fisher Scientific (TMO) currently carries a KC Score of 97 out of 100 — a grade of A+. In plain terms: strong, established uptrend with positive momentum. The score is a transparent, rules-based read of roughly the last twelve months of Thermo Fisher Scientific's daily closing prices. It describes momentum, trend, range position and stability — it is not a buy or sell recommendation, and it knows nothing about Thermo Fisher Scientific's valuation, earnings or news. At the last hourly update the stock traded near USD678.39, up 2.0% on the session, sitting 98% of the way up its 52-week range and about 0.7% below its 52-week high.

Momentum scores 100 out of 100. Over the past three months Thermo Fisher Scientific has moved 34.1%, and 38.2% over six months — a broadly positive run that lifts the momentum reading. On trend (100/100), the price is above its 50-day moving average and above its 200-day average. Both averages sitting below the price is the classic shape of an established uptrend.

Range position scores 98/100: at 98% of its 52-week band, Thermo Fisher Scientific is trading toward the top of where it has been over the last year. Stability scores 78/100, off annualised volatility of about 31% — moderate for a single stock. Lower volatility means steadier day-to-day movement, though it is never a guarantee against a large fall.

For a long-term investor, one stock's score matters far less than the system around it: keeping costs low, staying diversified, and giving compounding time to work. Treat TMO's reading as a single input, not a verdict, and compare it against other Healthcare names rather than in isolation. The math always wins — a low-cost, broadly diversified portfolio held for years reliably beats reacting to any one score, including this one.

Ad space
More Healthcare stocks
LLYEli LillyNVONovo NordiskUNHUnitedHealth GroupJNJJohnson & JohnsonVRTXVertex PharmaceuticalsHIMSHims & Hers Health
See the full Best Healthcare ranking →Compare TMO vs LLY →

Thermo Fisher Scientific (TMO) — frequently asked

Is the KC Score a buy or sell signal?

No. It is an educational, rules-based description of recent price behaviour — momentum, trend, range and stability. It carries no view on valuation, fundamentals or news, and nothing here is financial advice. Your capital is at risk.

What data is the score based on?

Roughly the last twelve months of daily closing prices from public market data. The same transparent formula is applied to every stock, so scores are comparable across the site.

How often does it update?

Prices and the score refresh hourly, automatically. You may see a slightly different reading later in the day as new prices come in.

Know how you actually invest

Hold TMO? See what your whole portfolio says about you.

AlphaScore reads your real trade history and names your investor type — your edge, your blind spots, your next moves. Your statement never leaves your device. Free.

Run AlphaScore — free